These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32998843)

  • 41. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
    Knight KR; Kraemer DF; Winter C; Neuwelt EA
    J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Efficacy of intratympanic infiltration of N-acetyl cysteine in cisplatin ototoxicity].
    Rosas-Gutiérrez GDC; Fernández-Hernández JP; Olea-González AI
    Rev Med Inst Mex Seguro Soc; 2023 Sep; 61(Suppl 2):S318-S322. PubMed ID: 38016189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD010885. PubMed ID: 29975402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAEv4.03 ototoxicity grading scales applied to 3,799 audiograms of childhood cancer patients treated with platinum-based chemotherapy.
    Clemens E; Brooks B; de Vries ACH; van Grotel M; van den Heuvel-Eibrink MM; Carleton B
    PLoS One; 2019; 14(2):e0210646. PubMed ID: 30763334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Hearing Impairment With Neurocognition in Survivors of Childhood Cancer.
    Bass JK; Liu W; Banerjee P; Brinkman TM; Mulrooney DA; Gajjar A; Pappo AS; Merchant TE; Armstrong GT; Srivastava D; Robison LL; Hudson MM; Krull KR
    JAMA Oncol; 2020 Sep; 6(9):1363-1371. PubMed ID: 32729886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2016 Aug; (8):CD010885. PubMed ID: 27498707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy.
    Baguley DM; Prayuenyong P
    Cancer Chemother Pharmacol; 2020 Feb; 85(2):245-250. PubMed ID: 31865419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa.
    Paken J; Govender CD; Pillay M; Feyasa M; Sewram V
    PLoS One; 2023; 18(4):e0283639. PubMed ID: 37014872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD010885. PubMed ID: 31961948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surveillance for ototoxicity in platinum-based chemotherapy using mobile health audiometry with extended high frequencies.
    Ehlert K; Heinze B; Graham MA; Swanepoel D
    J Laryngol Otol; 2023 Jan; 137(1):61-67. PubMed ID: 35611593
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The long-term impacts of hearing loss, tinnitus and poor balance on the quality of life of people living with and beyond cancer after platinum-based chemotherapy: a literature review.
    Phillips OR; Baguley DM; Pearson SE; Akeroyd MA
    J Cancer Surviv; 2023 Feb; 17(1):40-58. PubMed ID: 36637633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.
    Sanchez VA; Dinh PC; Rooker J; Monahan PO; Althouse SK; Fung C; Sesso HD; Einhorn LH; Dolan ME; Frisina RD; Travis LB
    J Cancer Surviv; 2023 Feb; 17(1):27-39. PubMed ID: 36637632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
    Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
    Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Randomized Controlled Trial Using Automated Technology for Improving Ototoxicity Monitoring in VA Oncology Patients.
    Konrad-Martin D; O'Connell Bennett K; Garinis A; McMillan GP
    Am J Audiol; 2021 Oct; 30(3S):870-886. PubMed ID: 34582263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carboplatin and ototoxicity: hearing loss rates among survivors of childhood medulloblastoma.
    Musial-Bright L; Fengler R; Henze G; Hernáiz Driever P
    Childs Nerv Syst; 2011 Mar; 27(3):407-13. PubMed ID: 20931205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early and Long-Term Ototoxicity Noted in Children Due to Platinum Compounds: Prevalence and Risk Factors.
    Romano A; Rivetti S; Brigato F; Mastrangelo S; Attinà G; Maurizi P; Galli J; Fetoni AR; Ruggiero A
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different infusion durations for preventing platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2014 Jun; (6):CD010885. PubMed ID: 24968257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of chemotherapy-induced inner ear damage on quality of life in cancer survivors: a qualitative study.
    Pearson SE; Caimino C; Shabbir M; Baguley DM
    J Cancer Surviv; 2022 Oct; 16(5):976-987. PubMed ID: 34398361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis.
    Dillard LK; Lopez-Perez L; Martinez RX; Fullerton AM; Chadha S; McMahon CM
    Cancer Epidemiol; 2022 Aug; 79():102203. PubMed ID: 35724557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective evaluation of cisplatin- and carboplatin-mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients.
    Nitz A; Kontopantelis E; Bielack S; Koscielniak E; Klingebiel T; Langer T; Paulides M
    Oncol Lett; 2013 Jan; 5(1):311-315. PubMed ID: 23255940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.